Aurora Cannabis (ACBFF) is a community minded, Canadian owned and operated company. Nestled in the shadow of the Rockies in Mountain View County, its plants are carefully brought to harvest in its purpose-built 55,200 square foot facility.

Fed with water from the Canadian Rockies, cared for in a state-of-the-art facility designed to produce the cleanest, safest medical cannabis available on the market, we're proud of its facility, its team and its product. Cultivating, harvesting, and selling Canadian Medical Marijuana, Aurora is your best chance to experience the healing power of nature.

On November 27th, 2015 Aurora was officially issued its license to sell. This marked a monumental step in the continued success and evolution of Aurora as one of Canada's top medical marijuana companies.

Aurora is one of 35 licensed producers across Canada and the only one located in Alberta. Boasting the second highest square footage approved for production in Canada, Aurora was the first applicant in the Country to construct a purpose-built facility, which can now be described as no less than state-of-the-art.

Because Alberta is one of the most business friendly provinces in the Country, Aurora is able to operate with lower overhead. Located in rural Alberta there is no cost for the fresh mountain-fed water used in the facility, and operations take place under the lowest corporate tax rates and power rates in the Country. There is also an abundance of Alberta farm credit programs available to Aurora and a number of Albertan Innovation programs.

Aurora is arguably the lowest cost-per-gram licensed producer in Canada. Being the most technologically advanced facility with the most highly regulatory experienced team makes it a company you’ll want to be a part of.

In the latest event on December 5, 2017 the Company has completed the acquisitions of Larssen Ltd, a globally leading greenhouse engineering and design consultancy, and that of H2 Biopharma, a late-stage ACMPR applicant based in Quebec.

H2 is currently completing a state-of-the-art, purpose-built 48,000 square foot cannabis production facility (the "Lachute facility"), less than an hour from Montreal, which, upon completion, is projected to produce approximately 4,500 kilograms of high-quality cannabis per annum, with significant expansion potential on 46 acres (19 hectares) of land, which H2 has the right to acquire for $136,000. Aurora Larssen Projects Ltd. ("ALPS"), which was recently incorporated as Aurora's greenhouse design and consulting arm, will play an important role in the completion of this newest Aurora facility to EU GMP standards. Tracking for $6 million in fiscal 2018 revenues, the Larssen transaction will be immediately accretive. Completion of the H2 facility is anticipated for early calendar 2018 with production, and therefore additional revenues, anticipated shortly thereafter.